Growth Metrics

Envoy Medical (COCH) FCF Payout Ratio (2024 - 2026)

Envoy Medical recorded quarterly FCF Payout Ratio of 0.62 in Q1 2026, down 197.05% quarter-over-quarter from 0.63 in Q4 2025, and down 89.44% year-over-year from 5.83 in Q1 2025.

Envoy Medical's FCF Payout Ratio history runs 3 years deep, the most recent figure standing at 0.62 for Q1 2026.

  • In Q1 2026, FCF Payout Ratio fell 89.44% year-over-year to 0.62; the TTM figure through Mar 2026 stood at 0.12 (changed N/A YoY), while the FY2025 annual figure was 0.0, up 99.33% from the prior year.
  • FCF Payout Ratio came in at 0.62 for Q1 2026 at Envoy Medical, down from 0.63 in the prior quarter.
  • In the past five years, FCF Payout Ratio ranged from a high of 0.63 in Q4 2025 to a low of 0.62 in Q1 2026.
  • A 3-year average of 0.17 and a median of 0.23 in 2025 frame the typical range for FCF Payout Ratio.
  • Across the five-year window, FCF Payout Ratio surged 571.01% in 2025 and slumped 89.44% in 2026, its largest moves.
  • Envoy Medical's FCF Payout Ratio stood at 0.13 in 2024, then jumped by 571.01% to 0.63 in 2025, then slumped by 197.05% to 0.62 in 2026.
  • According to Business Quant data, FCF Payout Ratio over the past three periods registered 0.62, 0.63, and 0.44 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Cover (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 1.20
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 0.81
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.40
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.08
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 0.25
10 Envoy Medical 48.11 Mn 22.86 Mn -274,000.00 -0.62

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -0.62
Dec 31, 2025 0.63
Sep 30, 2025 -0.44
Jun 30, 2025 -0.14
Mar 31, 2025 -0.33
Dec 31, 2024 -0.13